Clinical Trials Directory

Trials / Completed

CompletedNCT03811444

Simulated Clinical Use Testing On Safety Lancets (Test B)

Simulated Clinical Use Testing to Evaluate Sharps Injury Prevention Features of HTL-STREFA's Safety Lancets (Test A)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
HTL-Strefa S.A. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

A simulated clinical use testing on the HTL-Strefa's safety lancets

Detailed description

This study aims to evaluate the safety of the use of the safety lancets: Haemolance Plus, Prolance and MediSafe Solo in the prevention of NSI and to evaluate the user's opinion with regards to the handling characteristics of the medical devices. The simulated use clinical study will involve healthcare professionals (HCPs) who routinely use safety lancets to collect blood samples.

Conditions

Interventions

TypeNameDescription
DEVICEHaemolance Plus safety lancetHaemolance Plus safety lancet type 420 is a sterile, single use medical device designed for the sampling of capillary blood from the fingertip of patients
DEVICEProlance safety lancetProlance safety lancet type 430 is a sterile, single use medical device designed for the sampling of capillary blood from the fingertip of patients.
DEVICEMediSafe Solo safety lancetMediSafe Solo safety lancet type 520 is a sterile, single use medical device designed for the sampling of capillary blood from the fingertip of patients.

Timeline

Start date
2018-11-30
Primary completion
2018-12-13
Completion
2018-12-13
First posted
2019-01-22
Last updated
2019-01-22

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT03811444. Inclusion in this directory is not an endorsement.